Physician

Kevin A Guidry, M.D.

According to 2025 Medicare claims, Kevin Guidry, M.D. (NPI: 1407848146) practices dermatology in the Lake Charles, LA market, with the plurality of this provider's patient population coming from Calcasieu, LA. This provider's primary affiliated billing organization is DERMATOLOGY ASSOCIATES OF SWLA LLC (NPI: 1780663419; TIN: 202411849) and primary practice location at 70605-4171.

Guidry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,820 traditional Medicare patients, billed 12,341 HCPCS/CPT codes, and received $377,389 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 674 prescription claims across 325 beneficiaries totaling $123,452 in drug costs, led by Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc). Open Payments data shows 4 records totaling $131. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $307,293 to $123,452. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,017	11,439	$347,213
2016	1,993	12,525	$364,273
2017	1,879	11,876	$335,044
2018	1,998	12,672	$356,451
2019	2,036	12,764	$383,975
2020	1,795	11,976	$324,620
2021	1,803	12,261	$391,890
2022	1,804	12,358	$393,642
2023	1,788	12,543	$354,494
2024	1,820	12,341	$377,389

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	368	826	$307,293
2016	331	741	$323,378
2017	291	666	$298,824
2018	282	606	$170,143
2019	291	612	$198,280
2020	269	627	$236,716
2021	290	602	$166,635
2022	285	630	$241,350
2023	303	688	$207,487
2024	325	674	$123,452

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	357	402	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	850	1,065	$55
17000	Destruction of precancer skin growth, 1 growth	1,203	1,766	$36
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	751	929	$33
17003	Destruction of precancer skin growth, 2-14 growths	963	6,274	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	66	1,555	$3,249
Clobetasol Propionate	Clobetasol Propionate	45	1,096	$1,918
Ketoconazole	Ketoconazole	86	1,974	$1,284
Fluorouracil	Fluorouracil	15	451	$1,004
Fluocinonide	Fluocinonide	27	765	$925

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$131	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin A. Guidry, M.D.?

Tedicare shows public-source Medicare data for Kevin A. Guidry, M.D. (NPI 1407848146), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin A. Guidry, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kevin A. Guidry, M.D.?

Kevin A. Guidry, M.D. is linked to DERMATOLOGY ASSOCIATES OF SWLA LLC (billing NPI 1780663419) in the available physician profile data.

Does Kevin A. Guidry, M.D. have Open Payments data?

Kevin A. Guidry, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.